Literature DB >> 21620107

Examination of claudin-1 expression in patients undergoing liver transplantation owing to hepatitis C virus cirrhosis.

G Zadori1, F Gelley, P Torzsok, E Sárváry, A Doros, A P Deak, P Nagy, Z Schaff, A Kiss, B Nemes.   

Abstract

The cell adhesion molecule claudin-1 (CLDN-1) is a well known co-factor for the cell entry of hepatitis C virus (HCV). We examined 24 hepatic biopsies from liver transplant patients. Reverse transcriptase polymerase chain reaction (RT-PCR) and immunohistochemistry were performed according to standard procedures. RT-PCR results were shown as relative expression (ΔCT) with beta-actin as the reference gene. Immunohistochemistry results are shown by morphometry. The CLDN-1 mRNS expression rate was significantly lower when the patient displayed favorably with an unsatisfactory to antiviral therapy 0.756 ± 0.249 versus 1.304 ± 0.28 (P=.012). There was also a strong positive correlation between CLDN-1 protein expression and liver fibrosis (Pearson correlation coefficients: r=0.476; P=.034).
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21620107     DOI: 10.1016/j.transproceed.2011.03.066

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


  5 in total

Review 1.  Histopathological evaluation of recurrent hepatitis C after liver transplantation: a review.

Authors:  Francesco Vasuri; Deborah Malvi; Elisa Gruppioni; Walter F Grigioni; Antonia D'Errico-Grigioni
Journal:  World J Gastroenterol       Date:  2014-03-21       Impact factor: 5.742

2.  Expression of Tight Junction Components in Hepatocyte-Like Cells Differentiated from Human Embryonic Stem Cells.

Authors:  Boglárka Erdélyi-Belle; György Török; Ágota Apáti; Balázs Sarkadi; Zsuzsa Schaff; András Kiss; László Homolya
Journal:  Pathol Oncol Res       Date:  2015-04-07       Impact factor: 3.201

3.  Heterogeneous claudin-1 expression in human liver.

Authors:  Helen J Harris; Garrick K Wilson; Stefan G Hübscher; Jane A McKeating
Journal:  Hepatology       Date:  2013-02       Impact factor: 17.425

Review 4.  Tight Junction Proteins and the Biology of Hepatobiliary Disease.

Authors:  Natascha Roehlen; Armando Andres Roca Suarez; Houssein El Saghire; Antonio Saviano; Catherine Schuster; Joachim Lupberger; Thomas F Baumert
Journal:  Int J Mol Sci       Date:  2020-01-28       Impact factor: 5.923

Review 5.  Tight junction proteins in gastrointestinal and liver disease.

Authors:  Mirjam B Zeisel; Punita Dhawan; Thomas F Baumert
Journal:  Gut       Date:  2018-10-08       Impact factor: 31.793

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.